Company Filing History:
Years Active: 2011
Title: Charles Roger Burghardt - Innovator in Adiponectin Research
Introduction
Charles Roger Burghardt is an accomplished inventor based in Mahwah, New Jersey. He has made significant contributions to the field of biochemistry, particularly focused on human adiponectin. With one patent to his name, Burghardt's work is instrumental in advancing our understanding of this important protein and its variations.
Latest Patents
Burghardt's notable patent is titled "Characterization and identification of unique human adiponectin isoforms and antibodies." This innovation pertains to methods for measuring different forms of human adiponectin present in human plasma or serum. The methods are based on an ELISA assay, utilizing various monoclonal antibodies directed against adiponectin, in combination with different polyclonal antibodies that target specific domains of human adiponectin. This invention also includes unique isoforms of adiponectin and the corresponding antibodies, further enhancing the tools available for research in this area.
Career Highlights
Currently, Burghardt is employed with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has allowed him to leverage his expertise in biochemistry to innovate in the field of human health. His contributions are crucial for creating more effective diagnostic and therapeutic options for various health conditions.
Collaborations
Throughout his career, Burghardt has collaborated with notable peers, including Jarema Peter Kochan and Erik Roy Rasmussen. These collaborations have facilitated the exchange of ideas and knowledge, leading to substantial advancements in research related to adiponectin.
Conclusion
Charles Roger Burghardt's work exemplifies the vital role of innovation in the biomedical field. His patent related to adiponectin is not just a testament to his inventiveness, but also a valuable contribution to the scientific community that aids in understanding and addressing health challenges. As he continues to develop his research, Burghardt's work is likely to have lasting impacts on both science and healthcare.